As pharmaceutical manufacturers impose stricter “rules of engagement” on contract pharmacy arrangements, many covered entities (CEs) are seeing significant reductions in access to 340B pricing for eligible NDCs. These changes limit the savings that once supported critical patient care initiatives and operational sustainability. In response, Verity Solutions has introduced its Alternative Distribution Model (ADM)—a strategic solution that restores access, preserves compliance, and eliminates unnecessary burdens on covered entities. Key ADM advantages include:
- No CE participation fees maximize program savings without added costs
- Restores access to targeted NDCs and excluded 340B claims
- Maintains full compliance with manufacturer expectations and audit standards
- Supports full in-system ordering, ensuring seamless integration with existing workflows
Verity’s ADM equips covered entities with a streamlined, cost-effective way to regain lost 340B savings while upholding compliance, simplifying operations, and strengthening their long-term program strategy.
